Astrazeneca Pharmaceuticals recalls

Astrazeneca Pharmaceuticals has 6 recalls on record with the FDA and USDA, the earliest in 2013 and the latest reported on 22 Oct 2025. 1 is still ongoing. 1 was reported in the last 12 months.

Total recalls6since 2013

Last 12 months1reported

Class I117% of total

Ongoing1latest 22 Oct 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 1Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 1 17%Class II 4 67%Class III 1 17%

Why astrazeneca pharmaceuticals is recalled

Product types

Brands

Brilinta117%
Fasenra117%

By year

2025117%
2018117%
2017117%
2016117%
2015117%
2013117%

Ongoing astrazeneca pharmaceuticals recalls

1 active

Reported	Class	Recall	Company	Reason	Where
22 Oct 2025Drug	CLASS II	Fasenra (benralizumab) Injection, 30 mg/mL recalledFasenra	Astrazeneca Pharmaceuticals	Sterility	Nationwide

All astrazeneca pharmaceuticals recalls, newest first

6 total

Reported	Class	Recall	Company	Reason	Where
22 Oct 2025Drug	CLASS II	Fasenra (benralizumab) Injection, 30 mg/mL recalledFasenra	Astrazeneca Pharmaceuticals	Sterility	Nationwide
14 Mar 2018Drug	CLASS III	Lynparza (olaparib) capsules 50 mg recalled	AstraZeneca Pharmaceuticals	Potency & Assay	Nationwide
19 Jul 2017Drug	CLASS I	Brilinta (ticagrelor) tablets, 90 mg Professional Sample recalledBrilinta	AstraZeneca Pharmaceuticals	Other	Nationwide
30 Mar 2016Drug	CLASS II	Tudorza Pressair (aclindinium bromide inhalation powder) recalled	AstraZeneca Pharmaceuticals	Other	Nationwide
24 Jun 2015Drug	CLASS II	Nexium¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg recalled	AstraZeneca Pharmaceuticals	Other	Nationwide
14 Aug 2013Drug	CLASS II	Merrem I.V. (meropenem for injection) meropenem equivalent vial recalled	AstraZeneca Pharmaceuticals	Other	PR

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.